Did I hear during the shareholder meeting today th
Post# of 148326
(Total Views: 489)
Posted On: 09/12/2019 8:32:13 PM
Did I hear during the shareholder meeting today that the first patient in the phase 2 mTNBC trial was injected yesterday? If so, that’s a very important milestone for cancer. Hopefully they can enroll either patients in this trial and release some prelim results in the coming months.
(0)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼